Intrinsic value of GP-Act III Acquisition Corp. (GPAT)
Live fair value data for GP-Act III Acquisition Corp. (GPAT) is currently unavailable. Please check again shortly.
Current Price: $100.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is GP-Act III Acquisition Corp. (GPAT) undervalued or overvalued?
Based on the current model output, GP-Act III Acquisition Corp. appears to be overvalued with a downside of 2.00%.
Fair value vs market price — GP-Act III Acquisition Corp. (GPAT)
Unlock premium access to view the live fair value comparison against current market price for GPAT.
Frequently Asked Questions - GPAT
How is GPAT intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for GPAT.
Is GPAT undervalued or overvalued right now?
GPAT is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for GPAT: open their intrinsic value pages.
- HYACHaymaker Acquisition Corp. III
- TACOBerto Acquisition Corp.
- VACHVoyager Acquisition Corp.
- MBAVM3-Brigade Acquisition V Corp. Class A Ordinary shares
- ALFCenturion Acquisition Corp.
- CCIXChurchill Capital Corp IX Ordinary Shares
- RDAGRepublic Digital Acquisition Company Class A Ordinary Shares
- BEAGBold Eagle Acquisition Corp.